Nuclein
Mark Hunter is an experienced operations executive currently serving as Vice President of Operations at Nuclein since January 2025 and as an advisor at Bioness Medical, Inc. since 2025. Previously, Mark held the position of CEO at Harmonic Bionics, Inc. from September 2022 until June 2025, a tenure that included the company's acquisition by Bioness Medical. Prior roles include COO and Vice President of Operations at Luminex from 2011 to 2022 and various supply chain positions at Abbott from 2002 to 2011. Mark began a career in engineering at Intel Corporation from 1997 to 2002. Educational qualifications include a Bachelor of Science in Mechanical Engineering from The University of Texas at Austin and a Master of Business Administration from Arizona State University.
This person is not in any teams
This person is not in any offices
Nuclein
Nuclein is a biotechnology company that develops the Hand-Held Polymerase Chain Reaction test device for infectious diseases. The test device is a disposable, all-in-one, self-testing device for infectious disease diagnosis that does not require any technical expertise and provides battery-powered, sample-to-answer results in under one hour,without the need to mail in a sample.